Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K192832
    Date Cleared
    2020-02-21

    (142 days)

    Product Code
    Regulation Number
    892.1750
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    This device is indicated to acquire and display cross-sectional volumes of the whole body, to include the head.

    The Aquilion Prime SP has the capability to provide volume sets. These volume sets can be used to perform specialized studies, using indicated software/hardware, by a trained and qualified physician.

    AiCE (Advanced Intelligent Clear-IQ Engine) is a noise reduction that improves image quality and reduces image noise by employing Deep Convolutional Network methods for abdomen, pelvis, lung, cardiac, extremities, head and inner ear applications.

    Device Description

    The Aquilion Prime SP (TSX-303B/8) V10.2 with AiCE-i is a 40-row CT System that is intended to acquire and display cross-sectional volumes of the whole body, including the head. An optional Dynamic Volume CT Upgrade Kit can be installed in order to expand the active detector rows to 80. This system is based upon the technology and materials of previously marketed Canon CT systems. In addition, the subject device incorporates the latest reconstruction technology, AiCE-i (Advanced intelligent Clear-IQ Engine - integrated), intended to reduce image noise and improve image quality by utilizing Deep Convolutional Network methods. These methods can more fully explore the statistical properties of the signal and noise. By learning to differentiate structure from noise, the algorithm produces fast, high quality CT reconstruction.

    AI/ML Overview

    The Aquilion Prime SP (TSX-303B/8) V10.2 with AiCE-i is a CT x-ray system, and information on its acceptance criteria and the study proving it is provided below:

    • 1. A table of acceptance criteria and the reported device performance
    Acceptance Criteria (Claims)Reported Device Performance
    Improved Quantitative high contrast Spatial Resolution over AIDR 3D with reduced noiseConfirmed through MTF-Wire and MTF-Edge tests.
    Improved Quantitative Dose Reduction over FBP82% dose reduction relative to FBP.
    Better Low-contrast Detectability than AIDR 3D for abdomen at the same dose13.8% improved low contrast detectability compared to AIDR 3D.
    Noise appearance/texture more similar to high dose filtered backprojection compared to MBIRSupported by analysis of NPS and kurtosis values for FBP, FIRST, and AiCE. Claims state "Noise appearance/texture more similar to high dose filtered backprojection compared to MBIR," "Noise appearance/texture more similar to filtered backprojection compared to MBIR," "Improved noise appearance/texture compared to MBIR," and "More natural noise texture compared to MBIR."
    Reduced noise (quantitative)21.4% noise reduction at the same dose for the body compared to AIDR 3D.
    Low-contrast detectability of 1.5 mm at 0.3%, 21.8mGy, using AiCE BodyConfirmed through a phantom study.
    AiCE reconstructed images are of diagnostic quality for various applications (abdomen, pelvis, lung, cardiac, brain, extremities, and inner ear).Representative images for these applications were reviewed by an American Board Certified Radiologist and confirmed to be of diagnostic quality.
    Substantial equivalence in image quality metrics (CNR, CT Number Accuracy, Uniformity, SSP, SD, NPS, LCD, Pediatric phantom/protocol) compared to the predicate device.Concluded that AiCE images are substantially equivalent to the predicate device based on the results of performed phantom studies for these metrics.
    • 2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

      The document does not explicitly state a sample size for patient data. The testing primarily relies on phantom studies and a review of diagnostic images.

      • Data Provenance: Not specified for any potential patient data. The document mentions "Representative abdomen/pelvis, lung, cardiac, brain, extremities and inner ear diagnostic images" were obtained using the subject device, suggesting prospective acquisition for evaluation, but this is not definitively stated.
    • 3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

      For the assessment of diagnostic image quality:

      • Number of experts: One
      • Qualifications of experts: An "American Board Certified Radiologist." Further details (e.g., years of experience) are not provided.
    • 4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

      Based on the mention of a single American Board Certified Radiologist reviewing images, there was no multi-reader adjudication method (e.g., 2+1, 3+1) described for the diagnostic quality assessment. It appears to be a solitary expert's assessment.

    • 5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

      No multi-reader multi-case (MRMC) comparative effectiveness study focusing on human reader improvement with or without AI assistance is described in the provided text. The study focused on assessing image quality and specific performance metrics of the AI-integrated system (AiCE-i) through phantom studies and expert review of diagnostic images.

    • 6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

      Yes, standalone testing of the algorithm (AiCE-i) was a primary component of the study. This is evidenced by:

      • The extensive use of phantom studies to assess various image quality metrics (CNR, CT Number Accuracy, Uniformity, SSP, MTF, SD, NPS, LCD, etc.). These are objective measurements of the algorithm's output.
      • Direct claims stating quantitative dose reduction (82%) and noise reduction (21.4%) by the AiCE algorithm relative to other reconstruction methods.
      • Claims about improved low contrast detectability (13.8%) by the algorithm.
      • Analysis of NPS and kurtosis values to assess noise appearance/texture of the algorithm's output.
    • 7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

      The ground truth used for the evaluation can be categorized as follows:

      • Objective Phantom Measurements: For quantitative image quality metrics like dose reduction, noise reduction, CNR, MTF, NPS, and LCD. The "ground truth" here is the physical properties of the phantom and the established measurement methodologies.
      • Expert Radiologist Review: For confirming the "diagnostic quality" of the AiCE reconstructed images. The "ground truth" in this context is the qualitative assessment and professional judgment of the American Board Certified Radiologist.
    • 8. The sample size for the training set

      The document does not provide details on the sample size or characteristics of the training data used for the Deep Convolutional Network methods employed by AiCE-i.

    • 9. How the ground truth for the training set was established

      The document does not provide details on how the ground truth for the training set was established for the Deep Convolutional Network methods used by AiCE-i.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1